First Eagle Investment Management
FLXN

First Eagle Investment Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

First Eagle Investment Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38,841
Closed -$237K – 377
2021
Q3 		$237K Buy
38,841
+30,509
+366% +$190K ﹤0.01% 237
2021
Q2 		$69K Buy
+8,332
New +$70.9K ﹤0.01% 134

First Eagle Investment Management's FLXN Position: Q4 2021 in Review

First Eagle Investment Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 38,841 shares — an estimated $237K sold.

First Eagle Investment Management first reported a position in FLXN in Q2 2021 and held it in 2 quarters. The position peaked at $237K in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • First Eagle Investment Management reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • First Eagle Investment Management sold 38,841 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $237K.
  • First Eagle Investment Management first reported a position in Flexion Therapeutics, Inc. in Q2 2021 and held it in 2 quarters.
  • First Eagle Investment Management's Flexion Therapeutics, Inc. position peaked at $237K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on First Eagle Investment Management's 13F filing for Q4 2021, filed 10 Feb 2022.